CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Minoxidil Foam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03488108
NCT03488108Phase 2Completed
CompareCT.gov

A Randomized Controlled Trial Comparing Platelet Rich Plasma (PRP) to Minoxidil Foam for Treatment of Androgenic Alopecia in Women

Mayo Clinic·interventional·Posted Apr 4, 2018·Updated Apr 8, 2020

In Brief

A Phase 2 clinical trial evaluating Platelet Rich Plasma and Minoxidil Foam for Alopecia. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The primary objective of this proposal is to conduct a study that assesses the safety, feasibility and efficacy of using PRP to treat this type of hair loss.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlopecia
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedApr 4, 2018
Enrollment StartJan 23, 2017
Primary CompletionMay 31, 2018
Study CompletionJun 17, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.2 years ago

Interventions

Platelet Rich Plasmaother

Autologous Platelet Rich Plasma (PRP) will be isolated from blood collected from each subject at each treatment time point. 100 cc of PRP will be injected with a 30-gauge needle over the affected part of the scalp, approximately 1/10 cc/injection site. Treatments will take place every 4 weeks for a total of 3 treatments over 12 weeks.

Minoxidil Foamdrug

Minoxidil 5% topical foam will be applied once daily following manufacturer's instructions for a total of 12 weeks.